Peer Review reports
From: Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways
| Original Submission | ||
|---|---|---|
| 7 Dec 2018 | Submitted | Original manuscript |
| 17 Feb 2019 | Reviewed | Reviewer Report - Xiaochun Sun |
| 17 Mar 2019 | Reviewed | Reviewer Report - Jennifer Gunter |
| 15 May 2019 | Author responded | Author comments - José Esparza-López |
| Resubmission - Version 2 | ||
| 15 May 2019 | Submitted | Manuscript version 2 |
| 24 Jun 2019 | Reviewed | Reviewer Report - Xiaochun Sun |
| 3 Jul 2019 | Author responded | Author comments - José Esparza-López |
| Resubmission - Version 3 | ||
| 3 Jul 2019 | Submitted | Manuscript version 3 |
| 12 Jul 2019 | Author responded | Author comments - José Esparza-López |
| Resubmission - Version 4 | ||
| 12 Jul 2019 | Submitted | Manuscript version 4 |
| Publishing | ||
| 16 Jul 2019 | Editorially accepted | |
| 23 Jul 2019 | Article published | 10.1186/s12885-019-5945-1 |
You can find further information about peer review here.